Ether

Ether

SCHEMBL7767502

CC(N)C(C)(C)C(=O)O.CCOCC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRE P78334 2/20 0.35
GABRA6 Q16445 2/20 0.35
GABRG1 Q8N1C3 2/20 0.35
GABRG3 Q99928 2/20 0.35
GABRQ Q9UN88 2/20 0.35
ENPEP Q07075 2/20 0.31
ALDH1A1 P00352 2/20 0.31
SLC7A5 Q01650 2/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466827 0.84
SCHEMBL18824851 0.84
Water SCHEMBL7767504 0.82 ALDH1A1 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
Hydrochloric Acid SCHEMBL3507710 0.82 ALDH1A1 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
Alanine SCHEMBL14688036 0.75 GABRP (0.42) GABRPGABRDGABRA1GABRB1GABRG2
Pivalate SCHEMBL11039116 0.74 ALDH1A1 (0.40) ALDH1A1KDM4ETSHRALOX15HMGCR
Alanine SCHEMBL11163433 0.73 GABRP (0.41) GABRPGABRDGABRA1GABRB1GABRG2
Alanine SCHEMBL11163436 0.73 GABRP (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1370735 0.72 MMP8 (0.46) ALDH1A1KDM4ETSHRALOX15MMP8
SCHEMBL3391927 0.70 SLC1A2 (0.38) ALDH1A1MAPTPTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842153-B1 METHOD OF PREPARING NORBENZOMORPHANE AS AN INTERMEDIATE IN THE PREPARATION OF PHARMACEUTICALLY USEFUL BENZOMORPHANE DERIVATIVES, IN PARTICULAR (-)-(1R,5S,2\"R)-3'-HYDROXY-2-(2-METHOXYPROPYL)-5,9,9-TRIMETHYL-6,7-BENZOMORPHANE BOEHRINGER INGELHEIM PHARMA (DE) 2001-05-30 EP claimed
US-5945535-A Method of preparing norbenzomorphanes BOEHRINGER INGELHEIM KG (DE) 1999-08-31 US claimed